CROs Hoping for Research Burst in Second Half of 2003

Publication
Article
Pharmaceutical TechnologyPharmaceutical Technology-09-02-2003
Volume 27
Issue 9

CROs and contract manufacturers had a decent second quarter, but they are hoping that Big Pharma comes through with a burst of trial start-ups in the second half of 2003.

External Link - article-70123.pdf

Articles in this issue
September 2003
In the Spotlight September 2003
Counterfeiting, Compliance, and Controls
September 2003
The Fabrication And Evaluation of the Formulation Variables of a Controlled-Porosity Osmotic Drug Delivery System with Diltiazem Hydrochloride
Disposable Filtration Lightens Cleaning and Validation Load
CROs Hoping for Research Burst in Second Half of 2003
Positron Emission Particle Tracking Studies of a Wurster Process for Coating Applications
Improved Blister Packaging Benefits Consumers, Caregivers, and Drug Makers
Recent Videos
CPHI Milan 2024: Highlighting the Benefits of Integrated Services
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Buy, Sell, Hold: Cell and Gene Therapy
Related Content
Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Three New European Facilities Established by BioPharmaSpec for R&D

Feliza Mirasol
November 21st 2024
Article

Located in German, Italy, and Lithuania, the new European facilities will specialize in drug discovery and R&D services.

Drug Solutions Podcast: Unlocking the Latest Manufacturing Trends

Drug Solutions Podcast: Unlocking the Latest Manufacturing Trends

Felicity Thomas
July 11th 2023
Podcast

In this episode, Sergey Vlasenko from Agilent chats about bio/pharmaceutical manufacturing trends, with a particular focus on oligonucleotides.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Ascend Advanced Therapies Expands US Footprint in New Partnership

Susan Haigney
November 12th 2024
Article

Ascend is partnering with EW Healthcare Partners to expand capabilities in the United States.

Drug Solutions Podcast: Considering Biologic Drug Development and Manufacturing Holistically

Drug Solutions Podcast: Considering Biologic Drug Development and Manufacturing Holistically

Felicity Thomas
May 2nd 2023
Podcast

In this episode, Hanns-Christian Mahler and Andrea Allmendinger from ten23 health will discuss some key aspects of biologic drug development and manufacturing.

Question mark background | Image Credit: © Leigh-Prather - © Leigh Prather - stock.adobe.com

The Importance of Appropriate Supplier Oversight

Siegfried Schmitt
November 2nd 2024
Article

The product license holder must have a supplier oversight system in place, says Siegfried Schmitt, PhD, vice president, Technical, Parexel.

Communication between the manufacturing plant and retail stores. | Image Credit: © Cagkan - © Cagkan - stock.adobe.com

Abzena Expands Microbiology Laboratory Space

Susan Haigney
October 30th 2024
Article

The company will be expanding its quality control testing capabilities at its San Diego, Calif. biologics development and manufacturing site.